Annual CFO
-$75.81 M
-$13.22 M-21.13%
December 31, 2023
Summary
- As of February 7, 2025, ALT annual cash flow from operations is -$75.81 million, with the most recent change of -$13.22 million (-21.13%) on December 31, 2023.
- During the last 3 years, ALT annual CFO has fallen by -$41.50 million (-120.98%).
- ALT annual CFO is now -13776.71% below its all-time high of $554.30 thousand, reached on December 31, 2005.
Performance
ALT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$27.12 M
-$9.01 M-49.76%
September 30, 2024
Summary
- As of February 7, 2025, ALT quarterly cash flow from operations is -$27.12 million, with the most recent change of -$9.01 million (-49.76%) on September 30, 2024.
- Over the past year, ALT quarterly CFO has dropped by -$10.59 million (-64.02%).
- ALT quarterly CFO is now -1122.05% below its all-time high of $2.65 million, reached on June 30, 2015.
Performance
ALT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$78.12 M
-$6.63 M-9.28%
September 30, 2024
Summary
- As of February 7, 2025, ALT TTM cash flow from operations is -$78.12 million, with the most recent change of -$6.63 million (-9.28%) on September 30, 2024.
- Over the past year, ALT TTM CFO has dropped by -$2.31 million (-3.04%).
- ALT TTM CFO is now -11932.17% below its all-time high of $660.20 thousand, reached on June 30, 2006.
Performance
ALT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.1% | -64.0% | -3.0% |
| 3 y3 years | -121.0% | -52.6% | -12.3% |
| 5 y5 years | -707.4% | -1017.4% | -713.5% |
ALT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.1% | +3.1% | -100.5% | at low | -24.8% | +0.2% |
| 5 y | 5-year | -689.5% | +3.1% | -1254.5% | at low | -713.5% | +0.2% |
| alltime | all time | <-9999.0% | +3.1% | -1122.0% | at low | <-9999.0% | +0.2% |
Altimmune Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.12 M(+49.8%) | -$78.12 M(+9.3%) |
| Jun 2024 | - | -$18.11 M(+10.7%) | -$71.48 M(-1.8%) |
| Mar 2024 | - | -$16.36 M(-1.1%) | -$72.76 M(-4.0%) |
| Dec 2023 | -$75.81 M(+21.1%) | -$16.53 M(-19.3%) | -$75.81 M(-1.0%) |
| Sep 2023 | - | -$20.49 M(+5.7%) | -$76.58 M(+7.6%) |
| Jun 2023 | - | -$19.38 M(-0.1%) | -$71.15 M(+3.9%) |
| Mar 2023 | - | -$19.41 M(+12.1%) | -$68.47 M(+9.4%) |
| Dec 2022 | -$62.59 M(-20.0%) | -$17.31 M(+15.0%) | -$62.59 M(-6.9%) |
| Sep 2022 | - | -$15.05 M(-9.9%) | -$67.25 M(-3.9%) |
| Jun 2022 | - | -$16.70 M(+23.5%) | -$69.97 M(-3.1%) |
| Mar 2022 | - | -$13.53 M(-38.4%) | -$72.19 M(-7.7%) |
| Dec 2021 | -$78.24 M(+128.1%) | -$21.97 M(+23.6%) | -$78.24 M(+12.5%) |
| Sep 2021 | - | -$17.77 M(-6.1%) | -$69.55 M(+13.5%) |
| Jun 2021 | - | -$18.93 M(-3.3%) | -$61.28 M(+23.7%) |
| Mar 2021 | - | -$19.57 M(+47.3%) | -$49.53 M(+44.4%) |
| Dec 2020 | -$34.31 M(+257.3%) | -$13.28 M(+39.7%) | -$34.31 M(+49.0%) |
| Sep 2020 | - | -$9.51 M(+32.5%) | -$23.03 M(+44.4%) |
| Jun 2020 | - | -$7.17 M(+64.9%) | -$15.95 M(+34.7%) |
| Mar 2020 | - | -$4.35 M(+117.1%) | -$11.84 M(+23.3%) |
| Dec 2019 | -$9.60 M(+2.3%) | -$2.00 M(-17.5%) | -$9.60 M(-24.7%) |
| Sep 2019 | - | -$2.43 M(-20.7%) | -$12.76 M(+12.4%) |
| Jun 2019 | - | -$3.06 M(+44.8%) | -$11.35 M(+42.9%) |
| Mar 2019 | - | -$2.11 M(-59.0%) | -$7.94 M(-15.4%) |
| Dec 2018 | -$9.39 M(-53.6%) | -$5.16 M(+403.9%) | -$9.39 M(+3.9%) |
| Sep 2018 | - | -$1.02 M(-393.9%) | -$9.04 M(-26.4%) |
| Jun 2018 | - | $348.10 K(-109.8%) | -$12.28 M(-39.9%) |
| Mar 2018 | - | -$3.56 M(-26.0%) | -$20.43 M(+1.1%) |
| Dec 2017 | -$20.21 M(+218.2%) | -$4.81 M(+12.9%) | -$20.21 M(+19.6%) |
| Sep 2017 | - | -$4.26 M(-45.4%) | -$16.90 M(+16.3%) |
| Jun 2017 | - | -$7.81 M(+133.5%) | -$14.54 M(+74.3%) |
| Mar 2017 | - | -$3.34 M(+123.9%) | -$8.34 M(+31.3%) |
| Dec 2016 | -$6.35 M(+97.5%) | -$1.49 M(-21.1%) | -$6.35 M(-5.0%) |
| Sep 2016 | - | -$1.89 M(+17.5%) | -$6.69 M(+9.2%) |
| Jun 2016 | - | -$1.61 M(+18.9%) | -$6.12 M(+229.6%) |
| Mar 2016 | - | -$1.36 M(-25.9%) | -$1.86 M(-42.2%) |
| Dec 2015 | -$3.22 M | -$1.83 M(+37.8%) | -$3.22 M(-34.5%) |
| Sep 2015 | - | -$1.33 M(-150.0%) | -$4.91 M(-14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | $2.65 M(-197.8%) | -$5.71 M(-35.8%) |
| Mar 2015 | - | -$2.71 M(-23.0%) | -$8.89 M(+4.9%) |
| Dec 2014 | -$8.47 M(+18.2%) | -$3.52 M(+65.8%) | -$8.47 M(-24.4%) |
| Sep 2014 | - | -$2.12 M(+298.3%) | -$11.21 M(+14.8%) |
| Jun 2014 | - | -$533.30 K(-76.8%) | -$9.76 M(+0.4%) |
| Mar 2014 | - | -$2.29 M(-63.3%) | -$9.72 M(+35.6%) |
| Dec 2013 | -$7.17 M(+208.6%) | -$6.26 M(+824.6%) | -$7.17 M(+134.5%) |
| Sep 2013 | - | -$676.70 K(+36.6%) | -$3.06 M(+373.5%) |
| Jun 2013 | - | -$495.40 K(-290.2%) | -$645.50 K(-77.4%) |
| Mar 2013 | - | $260.40 K(-112.1%) | -$2.85 M(+22.9%) |
| Dec 2012 | -$2.32 M(-70.3%) | -$2.15 M(-223.7%) | -$2.32 M(+136.3%) |
| Sep 2012 | - | $1.73 M(-164.2%) | -$982.90 K(-84.5%) |
| Jun 2012 | - | -$2.70 M(-441.6%) | -$6.34 M(+28.5%) |
| Mar 2012 | - | $791.40 K(-198.3%) | -$4.93 M(-36.9%) |
| Dec 2011 | -$7.81 M(-47.5%) | -$805.10 K(-77.7%) | -$7.81 M(-43.1%) |
| Sep 2011 | - | -$3.62 M(+178.8%) | -$13.72 M(+17.6%) |
| Jun 2011 | - | -$1.30 M(-37.8%) | -$11.66 M(-7.2%) |
| Mar 2011 | - | -$2.09 M(-68.9%) | -$12.57 M(-15.4%) |
| Dec 2010 | -$14.86 M(-47.2%) | -$6.72 M(+330.2%) | -$14.86 M(+3.7%) |
| Sep 2010 | - | -$1.56 M(-29.1%) | -$14.33 M(-32.8%) |
| Jun 2010 | - | -$2.20 M(-49.7%) | -$21.31 M(-17.2%) |
| Mar 2010 | - | -$4.38 M(-29.1%) | -$25.76 M(-8.5%) |
| Dec 2009 | -$28.15 M(+113.2%) | -$6.18 M(-27.6%) | -$28.15 M(+9.2%) |
| Sep 2009 | - | -$8.54 M(+28.6%) | -$25.79 M(+14.5%) |
| Jun 2009 | - | -$6.65 M(-1.9%) | -$22.53 M(+53.3%) |
| Mar 2009 | - | -$6.77 M(+77.1%) | -$14.70 M(+11.4%) |
| Dec 2008 | -$13.20 M(-3.2%) | -$3.82 M(-27.7%) | -$13.20 M(+40.8%) |
| Sep 2008 | - | -$5.29 M(-546.5%) | -$9.38 M(+129.3%) |
| Jun 2008 | - | $1.18 M(-122.5%) | -$4.09 M(-22.5%) |
| Mar 2008 | - | -$5.27 M(+166.9%) | -$5.27 M(-66.9%) |
| Dec 2007 | -$13.64 M(+0.8%) | - | - |
| Mar 2007 | - | -$1.98 M(-59.5%) | -$15.92 M(+17.7%) |
| Dec 2006 | -$13.53 M(-2540.9%) | -$4.88 M(-47.5%) | -$13.53 M(+56.5%) |
| Sep 2006 | - | -$9.31 M(-3862.4%) | -$8.65 M(-1409.9%) |
| Jun 2006 | - | $247.40 K(-40.1%) | $660.20 K(+59.9%) |
| Mar 2006 | - | $412.80 K | $412.80 K |
| Dec 2005 | $554.30 K | - | - |
FAQ
- What is Altimmune annual cash flow from operations?
- What is the all time high annual CFO for Altimmune?
- What is Altimmune annual CFO year-on-year change?
- What is Altimmune quarterly cash flow from operations?
- What is the all time high quarterly CFO for Altimmune?
- What is Altimmune quarterly CFO year-on-year change?
- What is Altimmune TTM cash flow from operations?
- What is the all time high TTM CFO for Altimmune?
- What is Altimmune TTM CFO year-on-year change?
What is Altimmune annual cash flow from operations?
The current annual CFO of ALT is -$75.81 M
What is the all time high annual CFO for Altimmune?
Altimmune all-time high annual cash flow from operations is $554.30 K
What is Altimmune annual CFO year-on-year change?
Over the past year, ALT annual cash flow from operations has changed by -$13.22 M (-21.13%)
What is Altimmune quarterly cash flow from operations?
The current quarterly CFO of ALT is -$27.12 M
What is the all time high quarterly CFO for Altimmune?
Altimmune all-time high quarterly cash flow from operations is $2.65 M
What is Altimmune quarterly CFO year-on-year change?
Over the past year, ALT quarterly cash flow from operations has changed by -$10.59 M (-64.02%)
What is Altimmune TTM cash flow from operations?
The current TTM CFO of ALT is -$78.12 M
What is the all time high TTM CFO for Altimmune?
Altimmune all-time high TTM cash flow from operations is $660.20 K
What is Altimmune TTM CFO year-on-year change?
Over the past year, ALT TTM cash flow from operations has changed by -$2.31 M (-3.04%)